(Q71246811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

A phase II study of m-AMSA in patients with malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

G Falkson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

D A Vorobiof

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

H J Lerner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

94-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00254253

17 October 2019

exact match

0 references

cites work

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series

1 reference

12 December 2020

Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule

1 reference

12 December 2020

Combined doxorubicin and radiation therapy in malignant pleural mesothelioma

1 reference

12 December 2020

Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA)

1 reference

12 December 2020

Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)

1 reference

12 December 2020

Cardiac abnormalities after AMSA administration

1 reference

12 December 2020

Potential antitumor agents. 12. 9-Anilinoacridines

1 reference

12 December 2020

Potential antitumor agents. X. Bisquaternary salts

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6688764%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference